National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

<NOTICE> DEPARTMENT OF HEALTH AND HUMAN SERVICES <SUBAGY>National Institutes of Health</SUBAGY> <SUBJECT>National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting</SUBJECT> Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. <EXTRACT> <E T="03">Name of Committee:</E> National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Medical Countermeasures for Biodefense and Emerging Infectious Diseases Research and Direct Acting Antivirals (DAA). <E T="03">Date:</E> June 3-5, 2025. <E T="03">Time:</E> 9:00 a.m. to 5:00 p.m. <E T="03">Agenda:</E> To review and evaluate contract proposals. <E T="03">Place:</E> National Institute of Allergy and Infectious Diseases, National Institutes of Health Rocky Mountain Laboratories, 903 S Fourth St., Hamilton, MT 59840, 406-375-9641 (Virtual). <E T="03">Contact Person:</E> Kristin L. McNally, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, Rocky Mountain Laboratories, 903 S Fourth St., Hamilton, MT 59840, 406-375-9641, <E T="03">mcnallyk@nih.gov</E> . <FP>(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)</FP> </EXTRACT> <SIG> <DATED>Dated: May 12, 2025. </DATED> <NAME>David W. Freeman,</NAME> Supervisory Program Analyst, Office of Federal Advisory Committee Policy. </SIG> <FRDOC>[FR Doc. 2025-08655 Filed 5-14-25; 8:45 am]</FRDOC> </NOTICE>